REVEALED: 11 - The Real Truth

Analysts Say Acadia's Negative Pain Data Increases Focus On Pimavanserin For Alzheimer's-Related Psychosis

Acadia Pharmaceuticals Inc (NASDAQ:ACAD) announced the primary endpoint miss of the phase 2 POC study of ACP-044 in acute postoperative pain following bunionectomy, a surgical procedure that moves toes back into the correct position.  RBC Capital Markets writes that although trends of pain reduction were observed in the 400 mg QID ACP-044 arm compared…

Benzinga · Apr 19, 2022

Mizuho Slashes Qualcomm Price Target - Read Why

Mizuho analyst Vijay Rakesh lowered the price target on Qualcomm Inc (NASDAQ:QCOM) to $185 from $210 (35.1% upside) and kept a Buy rating.  The first half of 2022 brings "multiple headwinds" to China handset manufacturers from weaker 5G demand, extended COVID lockdowns, and a more competitive Apple Inc (NASDAQ:AAPL) iPhone.  The headwinds are driving potentially increased radio…

Benzinga · Apr 18, 2022

This Is What Whales Are Betting On Block

A whale with a lot of money to spend has taken a noticeably bearish stance on Block. Looking at options history for Block (NYSE:SQ) we detected 21 strange trades.

Benzinga · Apr 8, 2022

10 Biggest Price Target Changes For Tuesday

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

Benzinga · Mar 29, 2022

Read How Analysts Reacted To MongoDB Post Q4 Earnings Beat

Analysts remained positive on MongoDB Inc (NASDAQ:MDB) despite slashing their price targets on the stock post Q4 results. Barclays analyst Raimo Lenschow lowered the PT to $410 from $556 (25% upside) and kept an Overweight. Atlas growth accelerated again compared to previous years. Morgan Stanley kept an Overweight with an unchanged price target of $633 (90%…

Benzinga · Mar 9, 2022

Mizuho Upgrades This Water Treatment Company - Read Why

Mizuho analyst Brett Linzey upgraded Pentair PLC (NYSE:PNR) to Neutral from Underperform and raised the price target to $62 (an upside of 7%) from $60. The company's purchase of Manitowoc Ice business for a net price of $1.38 billion strengthens its commercial water franchise and should be meaningfully accretive to margins, states Linzey. Pentair recently agreed…

Benzinga · Mar 4, 2022

Read How Analysts Reacted To Broadcom's Q1 Results

Analysts boosted their price targets on Broadcom Inc (NASDAQ:AVGO) post Q1 FY22 results. Baird analyst Tristan Gerra raised the price target on Broadcom from $690 to $700 (21% upside) and kept an Outperform.  The analyst said strong demand continues and will likely accelerate year-over-year this quarter, driven by enterprise IT, hyper-scale and cloud, switches upgrades…

Benzinga · Mar 4, 2022

Anaplan Shares Pop As Analysts Cheer Q4 Earnings

Analysts raised their price targets on Anaplan Inc (NYSE:PLAN) post Q4 results. Mizuho analyst Siti Panigrahi raised the PT to $65 from $60 (26.7% upside) and kept a Buy.  The company posted Q4 results and raised its fiscal 2023 guide above consensus estimates, the latest back-office player to benefit from the enterprise spending resumption. Wells…

Benzinga · Mar 3, 2022

Here's How Analysts Reacted To Workday's Q4 Results

Analysts mostly raised their price targets on Workday Inc (NASDAQ:WDAY) post Q4 results. Wells Fargo analyst Michael Turrin raised the PT to $340 from $325 (39.1% upside) and kept an Overweight.  Turrin expects Workday shares will see a boost from Q4 results as the company delivered a clean set of Q4 metrics and a meaningful…

Benzinga · Mar 1, 2022

Why These Analysts Cut Beyond Meat's Price Target

Beyond Meat Inc (NASDAQ: BYND) reported a higher than the expected loss per share for the fourth quarter due to rising costs. Mizuho On Beyond Meat: John Baumgartner maintained a Neutral rating for the stock while lowering the price target from $59 to $45.

Benzinga · Feb 25, 2022